ကျောက်ကပ်ကင်ဆာ အသားစဥ်စစ်ဆေးခြင်း- ဘယ်အချိန်နှင့် ဘယ်လို

နောက်ဆုံး ပြင်ဆင်သည် ဧပြီ ၂၉၊ ၂၀၂၆

• Facebook
• အင်စတာဂရမ်
• တော်သေးတယ်။
• ကြေးနန်းစာ
• WhatsApp
• LinkedIn
• မေးလ်

Renal cancer is often a silent malignancy, but the increasing use of ultrasound and CT scan during routine health checkups has led to the incidental detection of Small Renal Masses (SRMs). SRMs are defined as solid kidney lesions smaller than 4 cm. Approximately 80% of SRMs turn out to be cancer and 20% are benign. Traditionally, urologists recommended surgery for all SRMs, but this sometimes resulted in unnecessary operations when the pathology came back benign — which is why renal mass biopsy has become increasingly utilized.

• ထိုင်းနိုင်ငံ ဆီးလမ်းကြောင်းဌာန ဘန်ကောက်ဆေးရုံ အွန်လိုင်းဘွတ်ကင်လုပ်ခြင်း။ 02-310-3009 bhquro@bdms.co.th
• Samitivej Sriracha ဆေးရုံ Chonburi 088-022-1445

Renal cancer biopsy was developed to prevent over-treatment of benign and low-grade tumors, and to guide the most suitable treatment modality for each individual. The biopsy is an outpatient procedure performed with the patient in a prone position. Local anesthesia is injected at the flank area over the targeted kidney, and tissue cores are sampled under ultrasound or CT guidance.

Technical considerations for renal cancer biopsy

1. Obesity – skin-to-mass distance may affect needle access
2. Position of the renal mass – posterior masses are easier to access than anterior masses
3. Number of biopsy cores – 2 to 3 cores are recommended for adequate sampling
4. Accuracy rate – up to 92% reported in the literature

Safety profile of renal cancer biopsy

1. Less than 2% complication rate – including perinephric hematoma, flank pain, hematuria, and pneumothorax
2. Massive bleeding is rare and almost always self-limited
3. Tumor seeding along the biopsy tract is nearly negligible with modern coaxial biopsy technique

Once pathology is available, the following management plan applies:

1. Renal cancer confirmed – treatment modality (surgery, ablation, or active surveillance) is tailored to each patient
2. Benign mass confirmed – regular imaging surveillance recommended; repeat biopsy is reconsidered if:
   • Tumor grows beyond 4 cm in maximum diameter
   • Growth rate exceeds 5 mm per year

Small renal mass management is a sensitive issue that requires shared decision-making and a strong doctor-patient relationship. Patients can understandably feel anxious about a possible kidney cancer without a clear treatment plan. Our approach is always to provide transparent, evidence-based guidance tailored to each individual.

ကျွန်ုပ်၏တရားဝင် ပင်မစာမျက်နှာသို့ သွားရောက်ကြည့်ရှုနိုင်ပါသည်။ ဒီမှာ.

Frequently Asked Questions About Renal Cancer Biopsy

What is a small renal mass (SRM) and does it need to be biopsied?

A small renal mass (SRM) is a solid kidney lesion less than 4 cm in size, typically detected incidentally on ultrasound or CT scan during a health checkup. Approximately 80% of SRMs are malignant and 20% are benign. Renal mass biopsy is recommended when the result will change the treatment plan — for example, to confirm malignancy before surgery, to guide ablation therapy, or to avoid unnecessary surgery in patients who are not surgical candidates. The procedure achieves up to 92% diagnostic accuracy.

Is renal mass biopsy safe?

Yes. Renal mass biopsy has a very low complication rate of less than 2%, with reported complications including perinephric hematoma, flank pain, hematuria, and pneumothorax. Massive bleeding is rare and almost always self-limited. Tumor seeding along the biopsy tract is nearly negligible with modern coaxial technique. The procedure is performed as an outpatient under local anesthesia with ultrasound or CT guidance.

What happens after renal mass biopsy results?

If the biopsy confirms renal cancer, treatment is tailored to the individual — options include surgical resection (partial or radical nephrectomy), ablation therapy, or active surveillance for low-risk tumors. If the biopsy confirms a benign mass, regular imaging surveillance is recommended. Repeat biopsy is reconsidered if the mass grows beyond 4 cm or at a rate exceeding 5 mm per year. All decisions are made collaboratively with the patient based on the latest evidence-based guidelines.

If you have been found to have a renal mass and would like a specialist evaluation, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. ပြ ခ ဂ ဃ င.

ရှောင်ကြဉ်ချက်: ဤအကြောင်းအရာကို ဘန်ကောက်ဆေးရုံဌာနချုပ်ရှိ ဘုတ်လက်မှတ်ရရှိထားသော ဆီးလမ်းကြောင်းနှင့် ဆီးအိမ်အထူးကု ဆရာဝန် ဒေါက်တာ ဆိုရာဝီ ဝီရာဆိုပွန်က ရေးသားပြီး ပြန်လည်သုံးသပ်ထားပါသည်။ ဤအကြောင်းအရာသည် ပညာရေးဆိုင်ရာ ရည်ရွယ်ချက်အတွက်သာ ရည်ရွယ်ထားပြီး ဆေးဘက်ဆိုင်ရာ အကြံဉာဏ် မဟုတ်ပါ။ မည်သည့် ဆေးကုသမှုကိုမဆို စတင်မပြုမီ အရည်အချင်းပြည့်မီသော ကျန်းမာရေးပညာရှင်တစ်ဦးနှင့် အမြဲတမ်း ဆွေးနွေးတိုင်ပင်ပါ။.